Drug and Device Development Outsourcing 2.0 - Soaring Beyond the CRO

January 9, 2023

ProPharma Group - the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries launched the Research Consulting Organization (RCO) model, a new type of research consulting and clinical service for biotech, pharma and device innovators to deliver bespoke solutions that bring life-saving drugs to market sooner and more cost effectively.


 

Download the Whitepaper

TAGS: Company News

Related Articles

Brian Katz, Chief Strategy Officer (CSO) / Head of Corporate Development
Press Releases

September 13, 2022

ProPharma announces the appointment of Bryan Katz as new Chief Strategy Officer (CSO) / Head of Corporate Development

ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the expansion of the senior leadership team to include Bryan Katz as the new Chief Strategy Officer (CSO) / Head...

Continue reading the blog post
Hands working on a laptop
Company News

September 1, 2022

ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company

Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...

Continue reading the blog post
Healthcare patient pouring a pill out of a medicine bottle.
Company News

March 2, 2021

ProPharma Group Announces the Acquisition of Diamond Pharma Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...

Continue reading the blog post